In 2017, the IOM issued a report on neurodevelopmental disorders. No where in the report did they reference the literature on the effect of mercury and aluminum on microglial activation. The also reported that there were no technologies available to detect microglial activation in the living brain.
This is not correct.
In this new IPAK initiative, we will write and publish a major Technology Assessment Review on the technologies that exist for detecting and measuring microglial activation in the living human brain.
Obviously, this would allow rapid, patient-specific feedback on treatments designed to alleviate microglial activation, hopefully allowing parents and their children's healthcare provides to determine which treatment options - and doses - are most helpful.
This project needs your support. Your generous donation will help this technical review come into existence.